GCG’s Q1 2024 Healthcare Industry Update provides an overview of the latest trends in the sector, including recent performance, valuation multiples, and the state of the middle-market M&A environment.

Key findings include the following:

• Public equities across the Healthcare sector experienced a strong performance in Q1 2024. Many market segments that had started to rebound in the latter part of 2023, coinciding with the Federal Reserve’s decision to pause interest rate hikes, maintained their positive momentum into Q1 2024.
• Deal volume and deal value in the Healthcare sector both experienced a decline in Q1 2024 from the prior quarter, aligning with broader middle market M&A trends.
• By sector, Biotechnology and Healthcare Technology remained at the forefront of Healthcare M&A activities across the board, accounting for a combined nearly half of all Healthcare deal flow. The Biotechnology sector is currently experiencing heightened activity, notably in the areas of weight loss and cancer treatment, both generating significant investor interest.

Click here for the full update.

See here for all Healthcare News and Updates

Get in Touch

Tell us a little about yourself and we will get in touch as soon as we can.